C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/00 (2006.01) C12P 21/06 (2006.01) C12Q 1/527 (2006.01) C12Q 1/68 (2006.01) G01N 33/50 (2006.01) G01N 33/53 (2006.01) G01N 33/567 (2006.01) G01N 33/573 (2006.01) G01N 33/574 (2006.01) G01N 33/68 (2006.01)
Patent
CA 2448112
Human LCE genes are identified as modulators of the p53 pathway, and thus are therapeutic targets for disorders associated with defective p53 function. Methods for identifying modulators of p53, comprising screening for agents that modulate the activity of LCE are provided.
L'invention concerne des gènes humains LCE identifiés comme étant des modulateurs de la voie p53 et, par conséquent, des cibles thérapeutiques pour des troubles associés à une fonction défectueuse de p53. L'invention concerne également des procédés d'identification de modulateurs de p53 consistant à effectuer un criblage d'agents modulant l'activité des LCE.
Belvin Marcia
Francis-Lang Helen
Friedman Lori
Funke Roel P.
Karim Felix D.
Bennett Jones Llp
Exelixis Inc.
LandOfFree
Lces as modifiers of the p53 pathway and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Lces as modifiers of the p53 pathway and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lces as modifiers of the p53 pathway and methods of use will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2018656